首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model
【24h】

Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model

机译:血小板减少症病毒在C57 / BL6小鼠模型中出现新发严重发热的发病机理

获取原文
获取原文并翻译 | 示例
       

摘要

The discovery of an emerging viral disease, severe fever with thrombocytopenia syndrome (SFTS), caused by SFTS virus (SFTSV), has prompted the need to understand pathogenesis of SFTSV. We are unique in establishing an infectious model of SFTS in C57/BL6 mice, resulting in hallmark symptoms of thrombocytopenia and leukocyto-penia. Viral RNA and histopathological changes were identified in the spleen, liver, and kidney. However, viral replication was only found in the spleen, which suggested the spleen to be the principle target organ of SFTSV. Moreover, the number of macrophages and platelets were largely increased in the spleen, and SFTSV colocalized with platelets in cytoplasm of macrophages in the red pulp of the spleen. In vitro cellular assays further revealed that SFTSV adhered to mouse platelets and facilitated the phagocytosis of platelets by mouse primary macrophages, which in combination with in vivo findings, suggests that SFTSV-induced thrombocytopenia is caused by clearance of circulating virus-bound platelets by splenic macrophages. Thus, this study has elucidated the pathogenic mechanisms of thrombocytopenia in a mouse model resembling human SFTS disease.
机译:由SFTS病毒(SFTSV)引起的新兴病毒性疾病,即严重的血小板减少症候群(SFTS)发烧的发现,促使人们需要了解SFTSV的发病机理。我们在C57 / BL6小鼠中建立SFTS感染模型方面是独特的,从而导致血小板减少和白细胞减少的标志性症状。在脾,肝和肾中鉴定出病毒RNA和组织病理学变化。然而,病毒复制仅在脾脏中发现,这表明脾脏是SFTSV的主要靶器官。此外,脾脏中巨噬细胞和血小板的数目大大增加,并且SFTSV与血小板在脾脏的红髓中的巨噬细胞的细胞质中共定位。体外细胞测定进一步揭示了SFTSV粘附于小鼠血小板并促进了小鼠原代巨噬细胞对血小板的吞噬作用,结合体内发现,表明SFTSV诱导的血小板减少症是由脾巨噬细胞清除循环的病毒结合血小板引起的。因此,该研究阐明了在类似于人SFTS疾病的小鼠模型中血小板减少的致病机制。

著录项

  • 来源
  • 作者单位

    Laboratory of Viral Hemorrhagic Fever, National Institute for Viral Disease Control and Prevention, China Center for Disease Control Beijing 102206, China;

    Laboratory of Viral Hemorrhagic Fever, National Institute for Viral Disease Control and Prevention, China Center for Disease Control Beijing 102206, China;

    Department of Toxicology, Beijing Center for Disease Control and Prevention, Beijing 100013, China;

    Laboratory of Viral Hemorrhagic Fever, National Institute for Viral Disease Control and Prevention, China Center for Disease Control Beijing 102206, China;

    Laboratory of Virus, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Beijing 100021, China;

    Laboratory of Viral Hemorrhagic Fever, National Institute for Viral Disease Control and Prevention, China Center for Disease Control Beijing 102206, China;

    Laboratory of Viral Hemorrhagic Fever, National Institute for Viral Disease Control and Prevention, China Center for Disease Control Beijing 102206, China;

    Laboratory of Viral Hemorrhagic Fever, National Institute for Viral Disease Control and Prevention, China Center for Disease Control Beijing 102206, China;

    Laboratory of Viral Hemorrhagic Fever, National Institute for Viral Disease Control and Prevention, China Center for Disease Control Beijing 102206, China;

    Laboratory of Virus, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Beijing 100021, China;

    Laboratory of Virus, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Beijing 100021, China;

    Laboratory of Viral Hemorrhagic Fever, National Institute for Viral Disease Control and Prevention, China Center for Disease Control Beijing 102206, China;

    Laboratory of Virus, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Beijing 100021, China;

    Laboratory of Viral Hemorrhagic Fever, National Institute for Viral Disease Control and Prevention, China Center for Disease Control Beijing 102206, China;

    Laboratory of Viral Hemorrhagic Fever, National Institute for Viral Disease Control and Prevention, China Center for Disease Control Beijing 102206, China;

    Laboratory of Viral Hemorrhagic Fever, National Institute for Viral Disease Control and Prevention, China Center for Disease Control Beijing 102206, China;

    Laboratory of Viral Hemorrhagic Fever, National Institute for Viral Disease Control and Prevention, China Center for Disease Control Beijing 102206, China;

    Laboratory of Viral Hemorrhagic Fever, National Institute for Viral Disease Control and Prevention, China Center for Disease Control Beijing 102206, China;

    Laboratory of Viral Hemorrhagic Fever, National Institute for Viral Disease Control and Prevention, China Center for Disease Control Beijing 102206, China;

    Laboratory of Virus, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Beijing 100021, China;

    Laboratory of Viral Hemorrhagic Fever, National Institute for Viral Disease Control and Prevention, China Center for Disease Control Beijing 102206, China;

    Department of Toxicology, Beijing Center for Disease Control and Prevention, Beijing 100013, China;

    Laboratory of Virus, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Beijing 100021, China;

    Laboratory of Viral Hemorrhagic Fever, National Institute for Viral Disease Control and Prevention, China Center for Disease Control Beijing 102206, China;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    animal model; phlebovirus; pathology; reduction of platelets macrophage infection;

    机译:动物模型静脉病毒病理;减少血小板巨噬细胞感染;
  • 入库时间 2022-08-18 00:40:27

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号